Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2008 Financi...(s (iii)the ultimate duration of therapy ...),Health

Date:2/9/2009

s, (iii) the ultimate duration of therapy for customers on service beyond 36 months, (iv) the incidence of customers with equipment deemed to be beyond its useful life that may be eligible for new equipment and therefore a new rental episode, and the coverage and billing requirements established by CMS for suppliers to receive payment for a new rental period, (v) payment amounts and coverage guidelines established by CMS to reimburse suppliers for maintenance of capped oxygen equipment, and (vi) the extent to which other government and private payors attempt to adopt new oxygen payment rules similar to those now in effect by Medicare. These estimates are subject to change as more information becomes available to the Company and the Company assumes no obligation to update these estimates after the date of this release.

In 2009, the Company will adopt FASB Staff Position No. APB 14-1, "Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement)." FSP APB 14-1 specifies that issuers of such instruments should separately account for the liability and equity components in a manner that will reflect the entity's non-convertible borrowing rate at the date of issuance when interest cost is recognized in subsequent periods. The Company will implement the FSP at the beginning of 2009 and that implementation will be reflected in all subsequent interim and annual periods. The FSP will be applied on a retrospective basis to instruments within its scope that are outstanding during any of the periods presented in the Company's annual financial statements. As a result of the implementation, the Company will record an additional $17.2 million of non- cash interest expense that, when combined with the $15.1 million of cash interest expense recognized on the Company's outstanding $550.0 million principal amount of 2.75% Series A and Series B convertible debentures, will reflect
'/>"/>

SOURCE Lincare Holdings Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results
2. Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering
3. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
4. Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results
5. Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
6. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results
7. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
8. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
9. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
10. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
11. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved